Tat-Dependent Translocation of an F420-Binding Protein of Mycobacterium tuberculosis

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Bashiri, Ghader ^a   Perkowski, Ellen F ^b   Turner, Adrian P ^a   Feltcher, Meghan E ^b   Braunstein, Miriam ^b   Baker, Edward N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL PROTEIN F420; BINDING PROTEIN; RV0132C PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL MEMBRANE; CELL MEMBRANE TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

BACTERIAL PROTEINS; CARRIER PROTEINS; CHROMATOGRAPHY, GEL; MEMBRANE TRANSPORT PROTEINS; MYCOBACTERIUM TUBERCULOSIS; OPEN READING FRAMES; PROTEIN TRANSPORT;

EID: 84867704147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045003     Document Type: Article

References (44)

1. Global Tuberculosis Control (2010) World Health Organization.
2. Duncan K, Barry CE III, (2004) Prospects for new antitubercular drugs. Curr Opin Microbiol 7: 460-465.
3. Selengut JD, Haft DH, (2010) Unexpected Abundance of Coenzyme F420-dependent enzymes in the Genomes of Mycobacterium tuberculosis and other Actinobacteria. J Bacteriol 192: 5788-5798.
4. Bashiri G, Rehan AM, Greenwood DR, Dickson JMJ, Baker EN, (2010) Metabolic engineering of cofactor F420 production in Mycobacterium smegmatis. PLoS ONE 5: e15803.
5. Bashiri G, Squire CJ, Moreland NJ, Baker EN, (2008) Crystal structures of F420-dependent glucose-6-phosphate dehydrogenase FGD1 involved in the activation of the anti-tuberculosis drug candidate PA-824 reveal the basis of coenzyme and substrate binding. J Biol Chem 283: 17531-17541.
6. Purwantini E, Daniels L, (1996) Purification of a novel coenzyme F420-dependent glucose-6-phosphate dehydrogenase from Mycobacterium smegmatis. J Bacteriol 178: 2861-2866.
7. Dogra M, Palmer BD, Bashiri G, Tingle MD, Shinde S, et al. (2010) Comparative bioactivation of the novel anti-tuberculosis agent PA-824 in Mycobacteria and a subcellular fraction of human liver. Br J Pharmacol.
8. Singh R, Manjunatha U, Boshoff HI, Ha YH, Niyomrattanakit P, et al. (2008) PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science 322: 1392-1395.
9. Taylor MC, Jackson CJ, Tattersall DB, French N, Peat TS, et al. (2010) Identification and characterization of two families of F420H2-dependent reductases from Mycobacteria that catalyse aflatoxin degradation. Mol Microbiol 78: 561-575.
10. Manjunatha UH, Boshoff H, Dowd CS, Zhang L, Albert TJ, et al. (2006) Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 431-436.
11. Purwantini E, Mukhopadhyay B, (2009) Conversion of NO2 to NO by reduced coenzyme F420 protects mycobacteria from nitrosative damage. Proc Natl Acad Sci U S A 106: 6333-6338.
12. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537-544.
13. Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, et al. (2004) Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infect Immun 72: 1733-1745.
14. DeMaio J, Zhang Y, Ko C, Young DB, Bishai WR, (1996) A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 93: 2790-2794.
15. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) ClustalW2 and ClustalX version 2. Bioinformatics 23: 2947-2948.
16. Bagos PG, Nikolaou EP, Liakopoulos TD, Tsirigos KD, (2010) Combined prediction of Tat and Sec signal peptides with hidden Markov models. Bioinformatics 26: 2811-2817.
17. Bashiri G, Squire CJ, Baker EN, Moreland NJ, (2007) Expression, purification and crystallization of native and selenomethionine labeled Mycobacterium tuberculosis FGD1 (Rv0407) using a Mycobacterium smegmatis expression system. Protein Expr Purif 54: 38-44.
18. Braunstein M, Bardarov SS, Jacobs WRJ, (2002) Genetic methods for deciphering virulence determinants of Mycobacterium tuberculosis. Methods Enzymol 358: 67-99.
19. Isabelle D, Simpson DR, Daniels L, (2002) Large-scale production of coenzyme F420-5,6 by using Mycobacterium smegmatis. Appl Environ Microbiol 68: 5750-5755.
20. Jacobson FS, Daniels L, Fox JA, Walsh CT, Orme-Johnson WH, (1982) Purification and properties of an 8-hydroxy-5-deazaflavin-reducing hydrogenase from Methanobacterium thermoautotrophicum. J Biol Chem 257: 3385-3388.
21. Flores AR, Parsons LM, Pavelka MS Jr, (2005) Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 151: 521-532.
22. McDonough JA, Hacker KE, Flores AR, Pavelka MS Jr, Braunstein M, (2005) The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial beta-lactamases. J Bacteriol 187: 7667-7679.
23. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs JWR, (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 4: 1911-1919.
24. Gibbons HS, Wolschendorf F, Abshire M, Niederweis M, Braunstein M, (2007) Identification of two Mycobacterium smegmatis lipoproteins exported by a SecA2-dependent pathway. J Bacteriol 189: 5090-5100.
25. D'Orazio M, Folcarelli S, Mariani F, Colizzi V, Rotilio G, et al. (2001) Lipid modification of the Cu,Zn superoxide dismutase from Mycobacterium tuberculosis. Biochem J 359: 17-22.
26. Gurumurthy M, Mukherjee T, Dowd CS, Singh R, Niyomrattanakit P, et al. (2012) Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles. FEBS J 279: 113-125.
27. Sutcliffe IC, Harrington DJ, (2004) Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol Rev 28: 645-659.
28. Berks BC, Sargent F, De Leeuw E, Hinsley AP, Stanley NR, et al. (2000) A novel protein transport system involved in the biogenesis of bacterial electron transfer chains. Biochim Biophys Acta 1459: 325-330.
29. Gralnick JA, Vali H, Lies DP, Newman DK, (2006) Extracellular respiration of dimethyl sulfoxide by Shewanella oneidensis strain MR-1. Proc Natl Acad Sci U S A 103: 4669-4674.
30. Thompson BJ, Widdick DA, Hicks MG, Chandra G, Sutcliffe IC, et al. (2010) Investigating lipoprotein biogenesis and function in the model Gram-positive bacterium Streptomyces coelicolor. Mol Microbiol.
31. Valente FM, Pereira PM, Venceslau SS, Regalla M, Coelho AV, et al. (2007) The [NiFeSe] hydrogenase from Desulfovibrio vulgaris Hildenborough is a bacterial lipoprotein lacking a typical lipoprotein signal peptide. FEBS Lett 581: 3341-3344.
32. Widdick DA, Hicks MG, Thompson BJ, Tschumi A, Chandra G, et al. (2011) Dissecting the complete lipoprotein biogenesis pathway in Streptomyces scabies. Mol Microbiol 80: 1395-1412.
33. Wickner W, Schekman R, (2005) Protein translocation across biological membranes. Science 310: 1452-1456.
34. Stephenson K, (2005) Sec-dependent protein translocation across biological membranes: evolutionary conservation of an essential protein transport pathway (review). Mol Membr Biol 22: 17-28.
35. Palmer T, Sargent F, Berks BC, (2005) Export of complex cofactor-containing proteins by the bacterial Tat pathway. Trends Microbiol 13: 175-180.
36. McDonough JA, McCann JR, Tekippe EM, Silverman JS, Rigel NW, et al. (2008) Identification of functional Tat signal sequences in Mycobacterium tuberculosis proteins. J Bacteriol 190: 6428-6438.
37. Marrichi M, Camacho L, Russell DG, DeLisa MP, (2008) Genetic toggling of alkaline phosphatase folding reveals signal peptides for all major modes of transport across the inner membrane of bacteria. J Biol Chem 283: 35223-35235.
38. DeLisa MP, Tullman D, Georgiou G, (2003) Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci U S A 100: 6115-6120.
39. Tullman-Ercek D, DeLisa MP, Kawarasaki Y, Iranpour P, Ribnicky B, et al. (2007) Export pathway selectivity of Escherichia coli twin arginine translocation signal peptides. J Biol Chem 282: 8309-8316.
40. Malen H, Pathak S, Softeland T, de Souza GA, Wiker HG, (2010) Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv. BMC Microbiol 10: 132.
41. Stover CK, Warrener P, VanDevanter DR, Sherman DR, Arain TM, et al. (2000) A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405: 962-966.
42. Berks BC, Palmer T, Sargent F, (2003) The Tat protein translocation pathway and its role in microbial physiology. Advances in microbial physiology 47: 187-254.
43. Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, et al. (2005) Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 102: 15629-15634.
44. Boshoff HI, Barry CE III, (2005) Tuberculosis- metabolism and respiration in the absence of growth. Nat Rev Microbiol 3: 70-80.